Results 211 to 220 of about 7,951,899 (374)

Chemical engineering of γδ T cells with cancer cell-targeting antibodies for enhanced tumor immunotherapy. [PDF]

Natl Sci Rev
Chen L, Cheng B, Yang Z, Zheng M, Chu T, Wang P, He T, Xue Y, Ren H, Zheng L, Zhou P, Li X, Zhu H, Guo H, Chen X, Lin J.   +15 more
europepmc   +1 more source

Tin perovskite solar cells with >1,300 h of operational stability in N₂ through a synergistic chemical engineering approach.

Joule, 2022
Sanchez-Diaz J, Sánchez RS, Masi S, Kreĉmarová M, Alvarez AO, Barea EM, Rodriguez-Romero J, Chirvony VS, Sánchez-Royo JF, Martinez-Pastor JP, Mora-Seró I.   +10 more
europepmc   +1 more source

The principle of the Archimedean screw in chemical engineering

, 1938
Walter Fuhrmann Rollman
openalex   +2 more sources

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

Chemical engineering and environmental challenges. Cyclic adsorption/reaction technologies: Materials and process together! [PDF]

J Environ Chem Eng, 2020
Rodrigues AE.
europepmc   +1 more source

Professor Ihab Farag, Department of Chemical Engineering [PDF]

, 2012
Casellini, Brigid C.
core   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

Recent Development of Nanomaterials for Chemical Engineering. [PDF]

Nanomaterials (Basel)
Cao M.
europepmc   +1 more source